Research presented at Digestive Disease Week 2018 aimed to determine the rates and identify predictors of serious adverse events with mono- and combo-therapy for Crohn disease and ulcerative colitis.
Research presented at Digestive Disease Week 2018 aimed to determine the rates and identify predictors of serious adverse events with mono- and combo-therapy for Crohn disease and ulcerative colitis.
Inflammatory bowel disease has evolved into a global disease in the 21st century. In a recent systematic review, researchers evaluated the incidence of inflammatory bowel disease in different regions of the world.
Inflammatory bowel disease has evolved into a global disease in the 21st century. In a recent systematic review, researchers evaluated the incidence of inflammatory bowel disease in different regions of the world.
A presentation on the first successful endoscopic management of a twisted J-pouch won both a Presidential Poster Award and ACG Case Reports Journal Award at the ACG Scientific Meeting on October 24.
A presentation on the first successful endoscopic management of a twisted J-pouch won both a Presidential Poster Award and ACG Case Reports Journal Award at the ACG Scientific Meeting on October 24.
A thorough update and review of the 2018 American College of Gastroenterology clinical guideline may provide a better blueprint to clinicians in the management of Crohn disease.
A thorough update and review of the 2018 American College of Gastroenterology clinical guideline may provide a better blueprint to clinicians in the management of Crohn disease.
Dr Allegretti discusses the difficulty of diagnosing and treating Clostridiodes difficile infection among patients with inflammatory bowel disease at the recent Advances in Inflammatory Bowel Disease regional meeting.
Dr Allegretti discusses the difficulty of diagnosing and treating Clostridiodes difficile infection among patients with inflammatory bowel disease at the recent Advances in Inflammatory Bowel Disease regional meeting.
In this video, Dr Emanuelle Bellaguarda recaps her presentation at the Advances in Inflammatory Bowel Disease regional meeting held on August 7, on Immune-Mediated Events Related to Medications.
In this video, Dr Emanuelle Bellaguarda recaps her presentation at the Advances in Inflammatory Bowel Disease regional meeting held on August 7, on Immune-Mediated Events Related to Medications.
Dr Click discusses his poster presentation from Digestive Disease Week 2022 about potential predictors for loss of remission among patients with ulcerative colitis with endoscopic remission.
Dr Click discusses his poster presentation from Digestive Disease Week 2022 about potential predictors for loss of remission among patients with ulcerative colitis with endoscopic remission.
Dr Barnes discusses his presentation at Digestive Disease Week 2022 about a state-wide registry created to track outcomes following ileal pouch-anal anastomosis.
Dr Barnes discusses his presentation at Digestive Disease Week 2022 about a state-wide registry created to track outcomes following ileal pouch-anal anastomosis.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...